Diligent Investors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-542
Closed -$236K 352
2025
Q1
$236K Buy
+542
New +$218K 0.06% 320
2024
Q4
Sell
-542
Closed -$282K 369
2024
Q3
$282K Hold
542
0.07% 278
2024
Q2
$294K Hold
542
0.07% 258
2024
Q1
$281K Hold
542
0.07% 265
2023
Q4
$256K Sell
542
-70
-11% -$32.4K 0.07% 262
2023
Q3
$267K Sell
612
-28
-4% -$12.7K 0.08% 239
2023
Q2
$284K Hold
640
0.08% 218
2023
Q1
$294K Buy
640
+54
+9% +$25.7K 0.09% 214
2022
Q4
$301K Sell
586
-59
-9% -$30K 0.1% 202
2022
Q3
$293K Hold
645
0.1% 190
2022
Q2
$311K Hold
645
0.11% 186
2022
Q1
$317K Hold
645
0.09% 197
2021
Q4
$299K Hold
645
0.08% 203
2021
Q3
$246K Hold
645
0.08% 200
2021
Q2
$246K Hold
645
0.08% 201
2021
Q1
$232K Hold
645
0.08% 203
2020
Q4
$207K Buy
+645
New +$198K 0.08% 197
2020
Q1
Sell
-678
Closed -$205K 188
2019
Q4
$205K Buy
+678
New +$187K 0.09% 199
2019
Q3
Sell
-712
Closed -$201K 217
2019
Q2
$201K Buy
712
+11
+2% +$3K 0.1% 201
2019
Q1
$201K Buy
+701
New +$203K 0.11% 185
2018
Q4
Sell
-731
Closed -$200K 194
2018
Q3
$200K Buy
+731
New +$190K 0.11% 183

Other funds holding ELV

Diligent Investors's ELV Position: Q2 2025 in Review

Diligent Investors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 542 shares — an estimated $236K sold.

Diligent Investors first reported a position in ELV in Q3 2018 and held it in 21 quarters. The position peaked at $317K in Q1 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Diligent Investors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Diligent Investors sold 542 Elevance Health shares in Q2 2025, an estimated $236K.
  • Diligent Investors first reported a position in Elevance Health in Q3 2018 and held it in 21 quarters.
  • Diligent Investors's Elevance Health position peaked at $317K in Q1 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Diligent Investors's 13F filing for Q2 2025, filed 22 Jul 2025.